Bio Essence Corp. Files Q1 2025 10-Q Report
Ticker: BIOE · Form: 10-Q · Filed: May 15, 2025 · CIK: 1723059
| Field | Detail |
|---|---|
| Company | Bio Essence CORP (BIOE) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Bio Essence Corp. filed its Q1 2025 10-Q. Check financials.
AI Summary
Bio Essence Corp. filed its quarterly report (10-Q) for the period ending March 31, 2025. The company, incorporated in California and headquartered in Irvine, CA, operates in the Pharmaceutical Preparations sector. This filing covers their financial performance and operational status for the first quarter of 2025.
Why It Matters
This 10-Q filing provides investors and stakeholders with an update on Bio Essence Corp.'s financial health and operational progress during the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly filing and does not inherently indicate elevated risk.
Key Players & Entities
- Bio Essence Corp. (company) — Filer of the 10-Q report
- March 31, 2025 (date) — End of the reporting period
- 20250331 (date) — Conformed period of report
- 20250515 (date) — Filing date
- Irvine, CA (location) — Principal executive offices location
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Bio Essence Corp.?
Bio Essence Corp. is in the Pharmaceutical Preparations industry, as indicated by its SIC code 2834.
When is the period covered by this 10-Q filing?
The quarterly period ended March 31, 2025.
Where is Bio Essence Corp. headquartered?
The company's principal executive offices are located at 2955 Main Street, Suite 300, Irvine, CA 92614.
What is the SEC file number for Bio Essence Corp.?
The commission file number for Bio Essence Corp. is 000-56263.
What is the state of incorporation for Bio Essence Corp.?
Bio Essence Corp. is incorporated in California.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Bio Essence Corp (BIOE).